In the fourth quarter of 2024, BB Biotech shares posted a total return of -2.7% in CHF and -3.5% in EUR. NAV performance improved, rising by 2.7% in CHF and 2.8% in EUR, though it declined by 4.3% in ...
Parag Parikh Flexi Cap Fund continues to outperform its benchmark and category averages with strong returns over various ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback